Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Julia M. Rosa"'
Publikováno v:
Frontiers in Behavioral Neuroscience, Vol 16 (2022)
Depression and anxiety are devastating disorders. Understanding the mechanisms that underlie the development of depression and anxiety can provide new hints on novel treatments and preventive strategies. Here, we summarize the latest findings reporti
Externí odkaz:
https://doaj.org/article/0ccf213457644f0ea724daa48cfb191c
Autor:
Leandro C. Brito, Thais C. Marin, Luan Azevêdo, Julia M. Rosa‐Silva, Steven A. Shea, Saurabh S. Thosar
Publikováno v:
Compr Physiol
Physiological function fluctuates across 24 h due to ongoing daily patterns of behaviors and environmental changes, including the sleep/wake, rest/activity, light/dark, and daily temperature cycles. The internal circadian system prepares the body for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::085c6eea860d043730df6b863a7a9379
https://doi.org/10.1002/cphy.c210036
https://doi.org/10.1002/cphy.c210036
Autor:
Thomas H. Lee, Malegaddi Devaki, Douglas A. Formolo, Julia M. Rosa, Andy S. K. Cheng, Suk-Yu Yau
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 20; Issue 7; Pages: 5371
Chemotherapy-induced cognitive impairment (chemobrain) and muscle wasting (cachexia) are persisting side effects which adversely affect the quality of life of cancer survivors. We therefore investigated the efficacy of physical exercise as a non-phar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bca30e50fd5ee40d9e0eb602d4c5ae1
Autor:
Daiane B. Fraga, Julia M. Rosa, Manuella P. Kaster, Ana Lúcia S. Rodrigues, Ana Lúcia Bertarello Zeni, Anderson Camargo, Ana Paula Dalmagro
Publikováno v:
Psychopharmacology. 238:2555-2568
Guanosine has been shown to potentiate ketamine’s antidepressant-like actions, although its ability to augment the anxiolytic effect of ketamine remains to be determined. This study investigated the anxiolytic-like effects of a single administratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc0ae07138031fc2606fa90d7ba73ad4
https://doi.org/10.1007/s00213-021-05879-8
https://doi.org/10.1007/s00213-021-05879-8
Autor:
Ingrid A.V. Wolin, Julia M. Rosa, Manuella P. Kaster, Anderson Camargo, Ana Lúcia S. Rodrigues
Publikováno v:
Metabolic Brain Disease. 36:351-359
Amyloid beta (Aβ), one of the main hallmarks of Alzheimer’s Disease (AD), may stimulate pattern recognition receptors (PRR) such as the NLRP3 inflammasome, inducing a pro-inflammatory state in the brain that contributes to disease development. Phy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de094713bb68d28f393ccb4806e5eae4
https://doi.org/10.1007/s11011-020-00646-8
https://doi.org/10.1007/s11011-020-00646-8
Publikováno v:
Frontiers in Behavioral Neuroscience
Frontiers in Behavioral Neuroscience, Frontiers, 2022, 16, ⟨10.3389/fnbeh.2022.828258⟩
Frontiers in Behavioral Neuroscience, Frontiers, 2022, 16, ⟨10.3389/fnbeh.2022.828258⟩
International audience; Depression and anxiety are devastating disorders. Understanding the mechanisms that underlie the development of depression and anxiety can provide new hints on novel treatments and preventive strategies. Here, we summarize the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7eadb6c8a275c1ef195cc27c054d21e
https://pubmed.ncbi.nlm.nih.gov/35299696
https://pubmed.ncbi.nlm.nih.gov/35299696
Autor:
Ingrid A.V. Wolin, Julia M. Rosa, Morgana Moretti, Ana Lúcia S. Rodrigues, Vivian B. Neis, Francis L. Pazini, Anderson Camargo, Priscila B. Rosa
Publikováno v:
Journal of Psychiatric Research. 115:103-112
The ketamine's potential for the treatment of refractory depression and anxiety has been considered one the most important discoveries in the last years, however, repeated use of ketamine is limited due to its side/adverse effects. Therefore, the sea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91a1e45deec42ab3427b48dd562e49d5
https://doi.org/10.1016/j.jpsychires.2019.05.017
https://doi.org/10.1016/j.jpsychires.2019.05.017
Autor:
Julia M, Rosa, Anderson, Camargo, Ingrid A V, Wolin, Manuella P, Kaster, Ana Lúcia S, Rodrigues
Publikováno v:
Metabolic brain disease. 36(2)
Amyloid beta (Aβ), one of the main hallmarks of Alzheimer's Disease (AD), may stimulate pattern recognition receptors (PRR) such as the NLRP3 inflammasome, inducing a pro-inflammatory state in the brain that contributes to disease development. Physi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::533a715e18555a1087ee7d84df38811e
https://pubmed.ncbi.nlm.nih.gov/33211258
https://pubmed.ncbi.nlm.nih.gov/33211258
Autor:
Ana Lúcia S. Rodrigues, Julia M. Rosa, Anderson Camargo, Francis L. Pazini, Aline Siteneski, Daiane B. Fraga, Morgana Moretti
Publikováno v:
Chemico-biological interactions. 332
The development of fast-acting antidepressants is crucial considering that conventional antidepressants require a long period to elicit therapeutic effects. Creatine, an ergogenic guanidine-like compound, stands out as a candidate to exert fast antid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e8dc4d79282264ed77271a130f7addb
https://pubmed.ncbi.nlm.nih.gov/33022268
https://pubmed.ncbi.nlm.nih.gov/33022268
Autor:
Ana Lúcia Bertarello Zeni, Carla I. Tasca, Julia M. Rosa, Ana Paula Dalmagro, Ana Lúcia S. Rodrigues, Manuella P. Kaster, Anderson Camargo
Publikováno v:
Neurochemistry international. 139
Augmentative treatment is considered the best second-option when a first-choice drug has partial limitations, particularly by allowing antidepressant dose reduction. Considering that ketamine has significant knock-on effects, this study investigated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23ed8e17c927e57cb5bb0be2b46f58d5
https://pubmed.ncbi.nlm.nih.gov/32652267
https://pubmed.ncbi.nlm.nih.gov/32652267